Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status Sort descending	Expiration Date	Program Official
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)	NOT-OD-22-202		Clinical Trial Not Allowed	04/16/2025	Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery	PAR-21-332 (R21 Clinical Trial Not Allowed)	R21	Clinical Trial Not Allowed	09/08/2024	Edward Sauter, M.D., Ph.D.
HEAL Initiative: Studies to Enable Analgesic Discovery	RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed)	R61, R33	Clinical Trial Not Allowed	01/16/2027	Rachel Altshuler, Ph.D.
HEAL Initiative: Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment	RFA-NS-22-034 (R01 Clinical Trial Not Allowed)	R01	Clinical Trial Not Allowed	12/07/2024	Rachel Altshuler, Ph.D.
Discovery and Development of Natural Products for Cancer Interception and Prevention	RFA-CA-23-028 (UG3/UH3 Clinical Trial Not Allowed)	UH3, UG3	Clinical Trial Not Allowed	06/14/2025	Altaf Mohammed, Ph.D.
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer	PAR-22-061 (R01 Clinical Trial Not Allowed)	R01	Clinical Trial Not Allowed	01/08/2025	Young Kim, Ph.D.
Basic Research in Cancer Health Disparities	PAR-21-323 (R21 Clinical Trial Not Allowed)	R21	Clinical Trial Not Allowed	09/08/2024	Asad Umar, D.V.M., Ph.D.
Basic Research in Cancer Health Disparities	PAR-21-324 (R03 Clinical Trial Not Allowed)	R03	Clinical Trial Not Allowed	09/08/2024	Asad Umar, D.V.M., Ph.D.